Cargando…
Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum
CONTEXT: The 2012 Endocrine Society Clinical Practice Guidelines recommend that men aged 50 years or older with a diagnosis of hypogonadism undergo bone mineral density (BMD) testing. OBJECTIVE: The objective of this study was to determine the frequency at which men aged 50 years or older with a dia...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469919/ https://www.ncbi.nlm.nih.gov/pubmed/36111272 http://dx.doi.org/10.1210/jendso/bvac129 |
_version_ | 1784788738477391872 |
---|---|
author | Goettemoeller, Travis Bena, James Pantalone, Kevin M |
author_facet | Goettemoeller, Travis Bena, James Pantalone, Kevin M |
author_sort | Goettemoeller, Travis |
collection | PubMed |
description | CONTEXT: The 2012 Endocrine Society Clinical Practice Guidelines recommend that men aged 50 years or older with a diagnosis of hypogonadism undergo bone mineral density (BMD) testing. OBJECTIVE: The objective of this study was to determine the frequency at which men aged 50 years or older with a diagnosis of hypogonadism undergo BMD testing, and if found to have low BMD, are subsequently treated with an osteoporosis medication. METHODS: A retrospective chart review was conducted at a large academic medical center. Inclusion requirements were an International Classification of Diseases (ICD)-9 or -10 code for hypogonadism at any time between July 1, 2012 and September 30, 2020. Patients were followed until the date of BMD assessment or censoring (September 30, 2021). BMD results and treatment with osteoporosis medication were recorded. RESULTS: A total of 10 169 men with hypogonadism were identified, of whom the mean age was 63.4 (± 9.2), 86.3% White, mean body mass index 31.3 with prevalence of chronic kidney disease, type 2 diabetes, and hypertension of 20.6%, 36.9%, and 68.2%, respectively. The percentage that underwent BMD testing was 7.2%, of which 352 (48.4%) and 87 (12.0%) had osteopenia and osteoporosis, respectively. Among the 87 patients with osteoporosis, 57.5% were treated with an osteoporosis medication. CONCLUSION: Only 7.2% of hypogonadal men underwent BMD testing, and among them, 12.0% were found to have osteoporosis. Among those with osteoporosis, 57.5% underwent treatment with osteoporosis medication. Further studies are needed to determine why so few men with hypogonadism undergo BMD assessment and what systems can be put in place to overcome this clinical conundrum. |
format | Online Article Text |
id | pubmed-9469919 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94699192022-09-14 Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum Goettemoeller, Travis Bena, James Pantalone, Kevin M J Endocr Soc Clinical Research Article CONTEXT: The 2012 Endocrine Society Clinical Practice Guidelines recommend that men aged 50 years or older with a diagnosis of hypogonadism undergo bone mineral density (BMD) testing. OBJECTIVE: The objective of this study was to determine the frequency at which men aged 50 years or older with a diagnosis of hypogonadism undergo BMD testing, and if found to have low BMD, are subsequently treated with an osteoporosis medication. METHODS: A retrospective chart review was conducted at a large academic medical center. Inclusion requirements were an International Classification of Diseases (ICD)-9 or -10 code for hypogonadism at any time between July 1, 2012 and September 30, 2020. Patients were followed until the date of BMD assessment or censoring (September 30, 2021). BMD results and treatment with osteoporosis medication were recorded. RESULTS: A total of 10 169 men with hypogonadism were identified, of whom the mean age was 63.4 (± 9.2), 86.3% White, mean body mass index 31.3 with prevalence of chronic kidney disease, type 2 diabetes, and hypertension of 20.6%, 36.9%, and 68.2%, respectively. The percentage that underwent BMD testing was 7.2%, of which 352 (48.4%) and 87 (12.0%) had osteopenia and osteoporosis, respectively. Among the 87 patients with osteoporosis, 57.5% were treated with an osteoporosis medication. CONCLUSION: Only 7.2% of hypogonadal men underwent BMD testing, and among them, 12.0% were found to have osteoporosis. Among those with osteoporosis, 57.5% underwent treatment with osteoporosis medication. Further studies are needed to determine why so few men with hypogonadism undergo BMD assessment and what systems can be put in place to overcome this clinical conundrum. Oxford University Press 2022-08-16 /pmc/articles/PMC9469919/ /pubmed/36111272 http://dx.doi.org/10.1210/jendso/bvac129 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Research Article Goettemoeller, Travis Bena, James Pantalone, Kevin M Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum |
title | Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum |
title_full | Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum |
title_fullStr | Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum |
title_full_unstemmed | Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum |
title_short | Lack of Bone Mineral Density Testing in Men With Hypogonadism: A Clinical Conundrum |
title_sort | lack of bone mineral density testing in men with hypogonadism: a clinical conundrum |
topic | Clinical Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469919/ https://www.ncbi.nlm.nih.gov/pubmed/36111272 http://dx.doi.org/10.1210/jendso/bvac129 |
work_keys_str_mv | AT goettemoellertravis lackofbonemineraldensitytestinginmenwithhypogonadismaclinicalconundrum AT benajames lackofbonemineraldensitytestinginmenwithhypogonadismaclinicalconundrum AT pantalonekevinm lackofbonemineraldensitytestinginmenwithhypogonadismaclinicalconundrum |